Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Dutch Healthcare Authority (NZa) has published DBC package for specialist medical care in 2019

At the request of health care providers and health insurers, Dutch Healthcare Authority (Nederlandse Zorgautoriteit, NZa) develops DBC products in the form of DBC package on an annual basis. The DBC package for 2019 (RZ19a) includes tables with the products related to the product structure of the DBC package, including the care activity table (Zorgactiviteiten) and the electronic list of medical specialties. Stakeholders can use it to analyze the changes and prepare for the contract negotiations for 2019.

DBC package for 2019 (RZ19a) is available at the NZa web-site.

The most important changes for 2019 are:

  • Telemonitoring consultation: healthcare providers can declare consultations on telemonitoring easier. During telemonitoring, the treatment of a patient is assessed from a distance. Sometimes telemonitoring can be a reason to see a patient. Healthcare providers have been bothered to bill that consultation up to now. More information can be found in the document Changes to DBC release RZ19a.
  • Tariffs for 2019: the tariffs for 2019 are almost fully indexed. In consultation with representatives of care providers, it was decided not to implement a comprehensive tariff review. Only for complex chronic lung failure, the cost research led to a tariff re-evaluation. The tariffs decreased (excluding indexation) by an average of 3% in 2019. More information can be found in the report Accountability DBC package 2019 (RZ19a).

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.